Effects of a combined supplementation of conjugated linoleic acid (CLA/Tonalin® SG1000T FFA) and probiotics (Vivomixx®/VSL#3) as add-on to a first-line immunotherapy in relapsing-remitting Multiple Sclerosis

Beteiligte Wissenschaftlerin:
Dr. rer. medic. Dipl.-Stat. M. Eveslage

Studienleitung:
Univ.-Prof. Dr. med. Luisa Klotz